Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jan 17;32(1):101188.
doi: 10.1016/j.omtm.2024.101188. eCollection 2024 Mar 14.

Recombinant AAV genome size effect on viral vector production, purification, and thermostability

Affiliations

Recombinant AAV genome size effect on viral vector production, purification, and thermostability

Nermin Ibreljic et al. Mol Ther Methods Clin Dev. .

Abstract

Adeno-associated virus (AAV) has shown great promise as a viral vector for gene therapy in clinical applications. The present work studied the effect of genome size on AAV production, purification, and thermostability by producing AAV2-GFP using suspension-adapted HEK293 cells via triple transfection using AAV plasmids containing the same GFP transgene with DNA stuffers for variable-size AAV genomes consisting of 1.9, 3.4, and 4.9 kb (ITR to ITR). Production was performed at the small and large shake flask scales and the results showed that the 4.9 kb GFP genome had significantly reduced encapsidation compared to other genomes. The large shake flask productions were purified by AEX chromatography, and the results suggest that the triple transfection condition significantly affects the AEX retention time and resolution between the full and empty capsid peaks. Charge detection-mass spectrometry was performed on all AEX full-capsid peak samples showing a wide distribution of empty, partial, full length, and copackaged DNA in the capsids. The AEX-purified samples were then analyzed by differential scanning fluorimetry, and the results suggest that sample formulation may improve the thermostability of AAV genome ejection melting temperature regardless of the packaged genome content.

Keywords: adeno-associated virus; anion exchange chromatography; capsid melting temperature; capsid titer; charge detection-mass spectroscopy; differential scanning fluorimetry; gene therapy; genome ejection melting temperature; triple transfection; viral genome titer.

PubMed Disclaimer

Conflict of interest statement

N.I. is a full-time employee at Sarepta Therapeutics, a company with interest in developing AAV technology, and B.E.D. is a full time employee at Megadalton Solutions, a company with interest in developing CD-MS technology. C.W.L. declares no competing interests.

Figures

None
Graphical abstract
Figure 1
Figure 1
GFP genome size effect on AAV production and encapsidation (A) One-way means and ANOVA analysis of the viral genome titer (vg/mL) by GFP genome size for study 1. A Student’s t test comparing each pair of GFP genome sizes is shown at right. The vg titer production of the 1.9 and 3.4 kb genomes are not significantly different (p < 0.2599) but are both significantly different from the 4.9 kb genome (p < 0.0001). (B) One-way means and ANOVA analysis of the purified vg/cp ratio (%) by GFP genome size for study 2. A Student’s t test comparing each pair of GFP genome sizes at right. The purified vg/cp ratio (%) of the 1.9 and 3.4 kb genomes are not significantly different from each other (p < 0.5133) but are each significantly different from the 4.9 kb genome (p < 0.015 and p < 0.046 respectively).
Figure 2
Figure 2
AEX chromatograms of AAV2-GFP purifications (A) Transfection condition 1 AAV2-GFP 1.9 kb. (B) Transfection condition 1 AAV2-GFP 3.4 kb. (C) Transfection condition 1 AAV2-GFP 4.9 kb. (D) Transfection condition 2 AAV2-GFP 1.9 kb. (E) Transfection condition 2 AAV2-GFP 3.4 kb. (F) Transfection condition 2 AAV2-GFP 4.9 kb. (G) Transfection condition 3 AAV2-GFP 1.9 kb. (H) Transfection condition 3 AAV2-GFP 3.4 kb. (I) Transfection condition 3 AAV2-GFP 4.9 kb.
Figure 3
Figure 3
CD-MS mass histogram results for AAV2-GFP AEX chromatography full capsid peaks (A) Transfection condition 1 AAV2-GFP 1.9 kb. (B) Transfection condition 1 AAV2-GFP 3.4 kb. (C) Transfection condition 1 AAV2-GFP 4.9 kb. (D) Transfection condition 2 AAV2-GFP 1.9 kb. (E) Transfection condition 2 AAV2-GFP 3.4 kb. (F) Transfection condition 2 AAV2-GFP 4.9 kb. (G) Transfection condition 3 AAV2-GFP 1.9 kb. (H) Transfection condition 3 AAV2-GFP 3.4 kb. (I) Transfection condition 3 AAV2-GFP 4.9 kb.
Figure 4
Figure 4
Genome ejection melting curves and SLS 473 intensity curve for AEX full and empty capsid peak samples (A) The genome ejection melting curve (blue) based on fluorescent intensity of SYBR Gold bound to DNA for condition 1 AAV2-GFP AEX full capsid peak 1.9 kb sample. The differential (red) is graphed as well to show the maxima, which would be the melting temperature, Tm. Tm1, avg. = 59.83°C and Tm2, avg. = 69.53°C. (B) The SLS 473 intensity curve (blue) showing aggregation of the condition 1 AAV2-GFP AEX full capsid peak 1.9 kb sample. Tagg., avg. = 71.78°C. (C) The genome ejection melting curve (yellow) based on fluorescent intensity of SYBR Gold bound to DNA for condition 1 AAV2-GFP AEX empty capsid peak 1.9 kb sample. The differential (red) is graphed as well to show the maxima, which would be the melting temperature, Tm. Tm, avg. = 71.93°C. (D) The SLS473 intensity curve (yellow) showing aggregation of the condition 1 AAV2-GFP AEX empty capsid peak 1.9-kb sample. Tagg., avg. = 69.99°C.

References

    1. U.S. Food and Drug Administration Cellular, Tissue, and Gene Therapies Advisory Committee Meeting #70 . Briefing Document; 2021. Toxicity Risks of Adeno-associated Virus (AAV) Vectors for Gene Therapy (GT)
    1. Segura M.M., Kamen A.A., Garnier A. Overview of Current Scalable Methods for Purification of Viral Vectors. Methods Mol. Biol. 2011;737:89–116. - PubMed
    1. Dickerson R., Argento C., Pieracci J., Bakhshayeshi M. Separating Empty and Full Recombinant Adeno-Associated Virus Particles Using Isocratic Anion Exchange Chromatography. Biotech. J. 2021;16 - PubMed
    1. Venkatakrishnan B., Yarbrough J., Domsic J., Bennett A., Bothner B., Kozyreva O.G., Samulski R.J., Muzyczka N., McKenna R., Agbandje-McKenna M. Structure and Dynamics of Adeno-Associated Virus Serotype 1 VP1-Unique N-Terminal Domain and Its Role in Capsid Trafficking. J. Virol. 2013;87:4974–4984. - PMC - PubMed
    1. Wang C., Mulagapati S.H.R., Chen Z., Du J., Zhao X., Xi G., Chen L., Linke T., Gao C., Schmelzer A.E., Liu D. Developing an Anion Exchange Chromatography Assay for Determining Empty and Full Capsid Contents in AAV6.2. Mol. Ther. Methods Clin. Dev. 2019;15:257–263. - PMC - PubMed

LinkOut - more resources